Third Circuit Court of Appeals Decision Removes State Law Recourse for Suicide after Depression Drug: Lead Plaintiff Attorney from Anapol Schwartz Outraged by Federal Infringement of State Police Power

Business Wire, April 9, 2008

PHILADELPHIA -- According to Anapol Schwartz attorney, Sol Weiss, one of the lead plaintiffs in a consolidated appeal decided yesterday in the Third Circuit Court of Appeals, "The FDA, a federal regulatory agency whose staff is appointed without any accountability to the public, has been granted blanket authority to allow drug companies to not warn consumers about dangerous side effects associated with taking their prescriptions. The Court's decision is very disappointing, as it violates our Constitution's principles of federalism and the balance of power between state and federal government. I hope that the U.S. Supreme Court carefully considers the importance of the checks and balances ensured in our Constitution when it hears arguments in Wyeth v. Levine. In the interim, I am personally visiting congressional representatives to educate them about the need to restore the FDA's accountability to the public. I also encourage others to contact their legislators to restore fairness and our critical system of checks and balances."

For more information on this adverse preemption decision and how it impacts consumers' rights, call Sol Weiss at 215-735-2098 or e-mail him at sweiss@anapolschwartz.com. For information about Weiss' victims' rights legal practice visit www.anapolschwartz.com.